scholarly journals RE3 TRENDS IN AND EFFECTS OF HIGH DEDUCTIBLE HEALTH PLAN (HDHP) AMONG PATIENTS WITH COGNITIVE IMPAIRMENT

2020 ◽  
Vol 23 ◽  
pp. S383
Author(s):  
A. Alnijadi ◽  
J. Wu ◽  
G. Reeder ◽  
K. Lu
2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 102-103
Author(s):  
Kevin Lu ◽  
Sam Li ◽  
Jing Yuan ◽  
Minghui Li

Abstract OBJECTIVES: High Deductible Health Plan (HDHP) is characterized by higher deductibles and lower monthly premiums. Nevertheless, health economists are concerned that HDHPs may reduce or delay needed care, which will ultimately lead to poorer access to care for chronically affected participants. The objectives of this research are 1) to investigate the HDHP enrollment trend over the past decade; and, 2) to determine the effects of HDHP on risks of financial access risks among adults with cognitive impairment (CI). METHODS: Data were obtained between 2010-2018 from National Health Interview Survey (NHIS). Financial access to healthcare was assessed based on 6 survey questions by CDC. For data analysis, simple T tests and Chisq tests were used where appropriate, with multi-variable logistic regressions implemented to evaluate the effects of HDHP on risks of financial access. RESULTS: Of the 103,649 enrollments, 1,148 were with cognitive impairment and 102,501 were without CI diagnosis. A 55% increase in HDHP registers with cognitive impairment was observed from 2010 (30.50%) to 2018 (47.24%). After controlling for confounding variables, patients with HDPHs were more likely to have risks of financial access compared to those without HDHP (OR= 1.313, 95% CI, 1.002-1.719, p=0.0483). CONCLUSIONS: HDHPs are intended to support effective care options and reduce health care costs. Our research among CI patients with HDHP experienced more financial access risks than those without HDHP, indicating that HDHPs might have unintended consequences of healthcare usage. Employers and health care decision-makers may need to consider providing compensation to those HDHP enrollers with CI.


Author(s):  
J. Frank Wharam ◽  
Jamie Wallace ◽  
Robert F. LeCates ◽  
Jeanne M. Madden ◽  
Fang Zhang ◽  
...  

Medical Care ◽  
2016 ◽  
Vol 54 (5) ◽  
pp. 466-473 ◽  
Author(s):  
J. Frank Wharam ◽  
Fang Zhang ◽  
Bruce E. Landon ◽  
Robert LeCates ◽  
Stephen Soumerai ◽  
...  

2019 ◽  
Vol 9 (3) ◽  
pp. 292-298
Author(s):  
Shan Xie ◽  
Qing Ye ◽  
Bhagyashree Katare ◽  
Denny Yu ◽  
Yuehwern Yih

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. 1029-1029
Author(s):  
Christine Leopold ◽  
Anita K. Wagner ◽  
Fang Zhang ◽  
Christine Lu ◽  
Craig Earle ◽  
...  

1029 Background: 50% of workers have high-deductible health plans (HDHP) that require major outofpocket (OOP) spending for cancerrelated care. The OOP burden among patients with advanced cancer in HDHPs is unknown. Our objective was to estimate OOP spending for women with metastatic breast cancer (mbc) stratified by health plan type. Methods: Our data source was administrative health insurance claims and enrollment data of members insured though a large national health plan. We included 7142 women age 25-64 with mbc who had at least 6 months enrollment before the diagnosis and at least 12 months followup. We used a time series design and plotted OOP spending stratified by HDHP vs low-deductible plan. Primary outcome measures included: (1) 20042012 calendar trends in total annual OOP spending, (2) monthly total OOP spending in the 6 months before and 24 months after women were diagnosed with mbc, and (3) monthly total OOP spending in the last 6 months of life. Plots were adjusted for age, socioeconomic status, race/ethnicity, and US region of residence, and we then conducted linear regression to assess for statistical significance of trends. Results: In 2004, average annual OOP spending for women with mbc cancer in low-deductible health plans was $1196.2 and increased to $2570 in 2012, a yearly increase of $159.2 (113.2205.2). For women in HDHP average OOP spending in 2004 amounted to $2648 and increased to $3736.4 in 2012, representing an annual increase of $160.4 per year (105.4215.4) Average OOP spending per person month peaked in the month of diagnosis to $1633.8 for women in HDHPs and to $643 among low-deductible plan members. Average OOP spending in the last 6 months of life were $285.7 per person month among low-plan ($1714.2 per 6 months) and $607.3 among HDHP ($3644 per 6 months). Conclusions: To our knowledge, this is the first analysis to estimate OOP spending for women with mbc accounting for enrollment in HDHPs versus low-deductible plans. We found that OOP spending is increasing over time and is high in the last 6 months of life. HDHP members with mbc faced much higher OOP spending than women in traditional plans across all analyses. Findings raise concerns that HDHPs could worsen access to mbc treatments.


JAMA ◽  
2007 ◽  
Vol 297 (10) ◽  
pp. 1093 ◽  
Author(s):  
J. Frank Wharam ◽  
Bruce E. Landon ◽  
Alison A. Galbraith ◽  
Ken P. Kleinman ◽  
Stephen B. Soumerai ◽  
...  

2011 ◽  
Vol 46 (5) ◽  
pp. 1382-1401 ◽  
Author(s):  
Sheila K. Reiss ◽  
Dennis Ross-Degnan ◽  
Fang Zhang ◽  
Stephen B. Soumerai ◽  
Alan M. Zaslavsky ◽  
...  

2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Robert B Penfold ◽  
Jeffrey T Kullgren ◽  
Irina Miroshnik ◽  
Alison A Galbraith ◽  
Virginia L Hinrichsen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document